Investalks 马来西亚中文投资论坛 - 与你一起通往财务自由之路

 找回密码
 注册

最近看过此主题的会员

楼主: ╰蓝铯峢痕

╰蓝铯峢痕专区:U-crest 联峰集团

  [复制链接]
x 1
发表于 2018-4-20 20:12 | 显示全部楼层

谢谢你的分享

x 0 我要送花

x 869
 楼主| 发表于 2018-5-14 10:56 | 显示全部楼层
SAPNRG,厉害!

点评

马子买回?  发表于 2018-5-14 22:15

x 2 我要送花

x 4
发表于 2018-5-14 16:49 | 显示全部楼层
恭喜楼主发财~

x 0 我要送花

x 869
 楼主| 发表于 2018-5-15 16:19 | 显示全部楼层
本帖最后由 ╰蓝铯峢痕 于 2018-5-15 16:21 编辑

不知大家是否有留意到之前个人所卖出的个股有部分已从下跌趋势扭转至上涨趋势了。(HUAAN)

个人投资组合(5月15日更新)

PPHB(2016年7月)
持有着。

LEESK(2017年1月)
持有着。

SAPNRG (2018年3月21日)
持有着。

HUAAN (2018年5月15日)
买入原因与之前买进SAPNRG的原因类似也就是焦炭价格已从3月25日结算的价格(1780)回弹至(1951)。
话说今日午盘时,该股突然从低点0.425直接上攻至0.47。(害得个人本来还以为庄需洗盘几日,才趁低价位逐步买入。哪知今天还是追高买入了些。)
这个月底即将出炉最新的季度报告,预计与前三个季度报告来得差不多。(实现连续四个季度内都赚取丰厚的盈利)
最后也就是由于该股业务位于中国,而不受投资者的青睐,再加上投资机构也未曾追踪该股,导致该股价值长期备受低估。
个人觉得有关该股合理价位至少应该在55仙以上。

点评

厉害继续分享  发表于 2018-5-16 23:42

x 4 我要送花

x 869
 楼主| 发表于 2018-5-30 16:58 | 显示全部楼层
本帖最后由 ╰蓝铯峢痕 于 2018-5-30 17:11 编辑
╰蓝铯峢痕 发表于 2018-5-15 16:19
不知大家是否有留意到之前个人所卖出的个股有部分已从下跌趋势扭转至上涨趋势了。(HUAAN)

个人投资组 ...


个人投资组合(5月30日更新)

PPHB(2016年7月)
持有着。

LEESK(2017年1月)
持有着。

SAPNRG (2018年3月21日)
持有着。

Profit & Loss (Latest)
卖出Huaan,亏了约30%。

这次是今年有史以来亏损最严重的个股,虽然出炉的业绩对比前一年同时期的业绩来得好,但或许是达不到大部分的投资者的预期,所导致的抛售,再加上马股今天因意大利脱欧危机(国际地缘政治影响),大选变天、政策未定种种因素导致大盘严重下跌也加剧了今日Huaan的跌幅。

点评

有亏吗 ? 不是 6仙开始买起的 ? 就算慢慢加码 ,也不会太多吧 。  发表于 2018-5-31 16:20
谢谢分享  发表于 2018-5-31 13:48

x 4 我要送花

x 869
 楼主| 发表于 2018-5-31 19:36 | 显示全部楼层
给予Kinz兄的回复

我先来说明一下这是我第四次再度买进该股,其余三轮所买进的票都在50仙以上的价位抛售了。而这次只是小买了一些,看看是否有机会从下跌趋势扭转至上涨趋势,怎知昨日就来个跳水,导致我(这次以40至45仙价位买进的货)亏了达三成。So, 这故事告诉你同支股票最多能玩三轮,三轮以后还得看庄家有没有心思做下去,没的话直接就来个跳水爆量抛售,散户们就不好受咯!

点评

亏钱没事,最重要 有学到东西.  发表于 2018-5-31 23:41
偷偷告诉你,我上星期有偷跟你445 买了点, 也是320 卖了, 烧到手. 哈哈 .  发表于 2018-5-31 23:40

x 6 我要送花

x 869
 楼主| 发表于 2018-7-13 11:10 | 显示全部楼层
╰蓝铯峢痕 发表于 2018-5-30 16:58
个人投资组合(5月30日更新)

PPHB(2016年7月)

个人投资组合(7月13日更新)

PPHB(2016年7月)
持有着。

LEESK(2017年1月)
持有着。

SAPNRG (2018年3月21日)
持有着。

TDM (2018年6月7日)
持有着。

UCREST (2018年7月10日)
持有着。

点评

不用客气。买卖股票还需自己做决定,他人分享最多只是提供一些建设性的建议罢了。  发表于 2018-7-20 22:01
谢谢蓝兄的无私分享,之前你在前面有介绍Ucrest,所以价钱在0.2++的时候有入手一些  发表于 2018-7-16 10:47
謝謝分享  发表于 2018-7-15 22:56
谢谢分享  发表于 2018-7-13 23:17

x 4 我要送花

x 869
 楼主| 发表于 2018-7-20 21:58 | 显示全部楼层
UCREST PARTNERS WITH BLOKHIN – THE LARGEST CANCER RESEARCH CENTER IN EUROPE

(19 July 2018, Kuala Lumpur) UCrest Berhad announced today that the Company has signed Memorandum of Understanding with Blokhin Russian Cancer Research Center, the largest cancer research center in Europe and one of the largest cancer research institutes in the world to bring online cancer research of protocols and medicines, collaboration with other doctors in other hospitals in research, clinical trials and provide medical services to patients, extending the medical services to every corner in the world through imedic™ platform.

Additionally, UCrest and Blokhin Cancer Research Center will jointly conduct research and development on cancer diagnosis and therapeutic using artificial intelligence (AI) technology, block chain and Internet of Things (IOT) technology in combating one of the deadliest and toughest diseases faced by mankind.

Through the D-to-D-to-P (Doctors to Doctors to Patients) or D-to-P (Doctors to Patients) models, cancer specialists or Multi-Discipline Team (MDT) from Blokhin Center will be able to provide diagnosis or second opinion and treatment plan to patients not just in Malaysia, but anywhere in the world. “Technologies have always been the key part of medical science, particularly in the diagnosis and therapeutic of cancer. We are delighted to work with UCrest in the initiative to incorporate the latest technology of artificial intelligence and imedic into our research and clinic trial in addition to delivery of services to the patients,” said Dr. Meshcheryakov Andrey Albertovich, Deputy Director of Blokhin Center of Ministry of Health, Russia.

“Blokhin Center is one of the leading cancer research centers in the world and they have many successes and breakthroughs in many areas of the cancer diagnosis and therapeutic. We are leading in the use of IOT, Block Chain and artificial intelligence technologies in various aspects in the medical development, our collaboration will definitely bring one of the most advance technologies in cancer treatment to the people everywhere” said Mr. Eg Kah Yee Chairman of UCrest Berhad. “We are also planning to establish joint venture or any form of collaboration between Blokhin, UCrest and the local hospitals or clinics in offering the best possible treatment to the cancer patients,” he added.

About UCrest:
UCrest is the leading mobile health platform developer and operator with its imedic™ Cloud Hospital used by thousands of doctors and patients in the US, Russia, China and other Asian countries. imedic™ is powered by advanced Artificial Intelligence and knowledge-based technology for comprehensive analysis of the health data of the users to produce timely and accurate health information.

visit www.unitedcresthealthcare.com, www.palettemm.com

About N N Blokhin Cancer Research Center
Founded in 1951, the mission of Blokhin is to conduct fundamental and applied scientific research in the precancerous diseases and tumours while providing top quality medical care to patients. The institute undertakes research in the field of tumour cell biology, mechanisms of carcinogenesis and tumour progression (molecular, virological, chemical, physical, genetic, cellular, and immunological aspects). It also carries out experimental and clinical development of new technologies in surgical treatment of cancer, and works to develop new drugs and diagnostics, radiation and combined therapy, as well as researching preventative measures. A key specialist area of the unit is paediatric oncology.

Visit www.ronc.ru

x 3 我要送花

发表回复

您需要登录后才可以回帖 登录 | 注册 |

本版积分规则

Google 搜索本站 搜索WWW

快速回复 返回顶部 返回列表